Browse studies

Find your next paid study

1 recruiting study matching your filters

A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma

This phase II/III trial tests the safety, side effects, and best dose of the drug cabozantinib in combination with standard chemotherapy, and to compare the ef…

High Grade OsteosarcomaLocalized OsteosarcomaMetastatic Osteosarcoma+1 more

National Cancer Institute (NCI)NCT05691478